manufacturers of glp-1 drugs Market Size to Hit USD 132.79 Bn by 2035 9 Companies Developing Next-Generation GLP-1

Endocrinology 158 , 42184232 (2017)

To do this, payers need to assess the long-term ROI of GLP-1s, including the benefits of reduced spend on high-cost comorbidities

It strengthens their nutraceutical and cardiac wellness portfolio

Neural Regen Res 20(3):613631 Singh D, Khan MA, Akhtar K, Arjmand F, Siddique HR (2022) Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress

This is concerning in populations with limited intake of preformed vitamin A (e.g., liver, eggs, dairy) or poor beta-carotene-to-retinol conversion due to BCMO1 gene variants or epigenetic suppression [11]

Supporting the gut at this level can lead to improvements that extend throughout the entire body